Inhibikase Therapeutics Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About IKT
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Find out what a historical investment in Inhibikase Therapeutics Inc would be worth today using our IKT stock calculator.
$186.19M
-
0.00%
642.19K
$1.56
$1.50
$1.55
$4.20
$1.33
Ready to start your investing journey with Stake?
Open an accountIKT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IKT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IKT
on Stake
Buy IKT from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of IKT from only US$10 with fractional shares
